CliffBio
small molecule

ARSENIC TRIOXIDE

ARSENIC TRIOXIDE

Loss of exclusivity—loss of exclusivity
CompanyNexus Labs →See this company's full patent-cliff portfolio

Drug detail

Brand nameARSENIC TRIOXIDE
Active ingredientARSENIC TRIOXIDE
Strength1MG/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalNovember 2018
Marketing statusRX

More from Nexus Labs

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ARSENIC TRIOXIDE patent cliff — loss of exclusivity — | CliffBio